Literature DB >> 17530378

Use of a screw and plate system for a transtrochanteric anterior rotational osteotomy for osteonecrosis of the femoral head.

Satoshi Ikemura1, Takuaki Yamamoto, Seiya Jingushi, Yasuharu Nakashima, Taro Mawatari, Yukihide Iwamoto.   

Abstract

BACKGROUND: We originally used two or three large cancellous screws for a transtrochanteric rotational osteotomy for osteonecrosis. Since January 2002, a screw and plate system (K-MAX Adjustable Angle Hip Screw) has been used to obtain more rigid fixation at the site of osteotomies. We investigated the clinical and radiological results of a transtrochanteric anterior rotational osteotomy.
METHODS: Between January 2000 and December 2001, a transtrochanteric anterior rotational osteotomy with large cancellous screws was performed in 25 hips of 22 patients, and between January 2002 and March 2005, the K-MAX Adjustable Angle Hip Screw was used in 44 hips of 40 patients for treatment of osteonecrosis of the femoral head. Japanese Orthopaedic Association (JOA) score, postoperative management, and radiographic appearances were investigated.
RESULTS: The mean preoperative JOA score was 60.8 +/- 12.1 points in the large cancellous screw group and 61.5 +/- 14.4 points in the K-MAX Adjustable Angle Hip Screw group. This improved to 86.1 +/- 13.3 points in the large cancellous screw group and 88.7 +/- 6.6 points in the K-MAX Adjustable Angle Hip Screw group at the final follow-up. Intentional varus angulations were obtained in 15 of 25 hips in the large cancellous screw group and in 36 of 44 hips in the K-MAX Adjustable Angle Hip Screw group. Altogether, 23 of 25 (92.0%) cases with large cancellous screws started partial weight-bearing 7 weeks after the operation, and 43 of 44 (97.7%) cases with the K-MAX Adjustable Angle Hip Screw started 5 weeks after the operation.
CONCLUSIONS: The K-MAX Adjustable Angle Hip Screw produced clinical results similar to those with the large cancellous screws. In addition, partial weight-bearing could be started 2 weeks earlier after a transtrochanteric anterior rotational osteotomy with the K-MAX Adjustable Angle Hip Screw.

Entities:  

Mesh:

Year:  2007        PMID: 17530378     DOI: 10.1007/s00776-007-1123-4

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  5 in total

1.  Treatment of femoral head osteonecrosis in the United States: 16-year analysis of the Nationwide Inpatient Sample.

Authors:  Aaron J Johnson; Michael A Mont; Audrey K Tsao; Lynne C Jones
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176

2.  Risk factor analysis for postoperative complications requiring revision surgery after transtrochanteric rotational osteotomy for osteonecrosis of the femoral head.

Authors:  Kazuyuki Karasuyama; Goro Motomura; Satoshi Ikemura; Jun-Ichi Fukushi; Satoshi Hamai; Kazuhiko Sonoda; Yusuke Kubo; Takuaki Yamamoto; Yasuharu Nakashima
Journal:  J Orthop Surg Res       Date:  2018-01-10       Impact factor: 2.359

3.  The choice of locking plate in the treatment of peri-implant femoral fracture eight years after trans-trochanteric rotational osteotomy: A case report.

Authors:  Takeshi Utsunomiya; Takuaki Yamamoto; Goro Motomura; Kazuyuki Karasuyama; Kazuhiko Sonoda; Yusuke Kubo; Hiroyuki Hatanaka; Yukihide Iwamoto
Journal:  Int J Surg Case Rep       Date:  2016-07-22

4.  Hip survival rate in the patients with avascular necrosis of femoral head after transtrochanteric rotational osteotomy: a systematic review and meta-analysis.

Authors:  Ying-Xing Xu; Yuan-Zhong Ren; Zhi-Ping Zhao; Ying-Zhen Wang; Teng Wang; Tao Li
Journal:  Chin Med J (Engl)       Date:  2019-12-20       Impact factor: 2.628

5.  Favorable Clinical and Radiographic Results of Transtrochanteric Anterior Rotational Osteotomy for Collapsed Subchondral Insufficiency Fracture of the Femoral Head in Young Adults.

Authors:  Kazuhiko Sonoda; Goro Motomura; Satoshi Ikemura; Yusuke Kubo; Takuaki Yamamoto; Yasuharu Nakashima
Journal:  JB JS Open Access       Date:  2017-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.